Challenges and opportunities in the advancement of nanomedicines

Journal of Controlled Release

Volumn 164, Issue 2, 2012, Pages 236-246

  Wei, Alexander ^a   Mehtala, Jonathan G ^a   Patri, Anil K ^b  

^a PURDUE UNIVERSITY   (United States)

^b FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

Author keywords

Active targeting; Drug delivery; Ligand density; Nanomedicine; Passive uptake; Size analysis

Indexed keywords

ACTIVE TARGETING; CLINICAL DEVELOPMENT; COMBINATION THERAPY; GENERAL METHOD; LIGAND DENSITY; LOW LEVEL; NANOCARRIERS; NANOMEDICINES; NANOPARTICLE SIZES; NONSPECIFIC ADSORPTION; PARTICLE ENGINEERING; PASSIVE UPTAKE; PRACTICAL METHOD; SCALABLE APPROACH; SIZE ANALYSIS; SYSTEMATIC EXPLORATION; TARGETED DELIVERY;

BIOCHEMISTRY; DRUG DELIVERY; LIGANDS; OPTIMIZATION; SURFACE CHEMISTRY;

MEDICAL NANOTECHNOLOGY;

CADMIUM SELENIDE; CHITOSAN; DENDRIMER; GOLD NANOPARTICLE; LIPOSOME; MACROGOL; NANOCARRIER; NANOPARTICLE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; POLYAMIDOAMINE; POLYGLACTIN; QUANTUM DOT; ZINC SULFIDE;

ACCURACY; ADSORPTION; ARTICLE; BIOCOMPATIBILITY; DENSITY; DRUG ACCUMULATION; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG COATING; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG MANUFACTURE; DRUG STABILITY; DRUG STORAGE; HUMAN; LIGHT SCATTERING; NANOCHEMISTRY; NANOENGINEERING; NANOMEDICINE; NONHUMAN; OPSONIZATION; PARTICLE SIZE; PRIORITY JOURNAL; SCALE UP;

ADSORPTION; ANIMALS; DRUG CARRIERS; HUMANS; NANOMEDICINE; NANOPARTICLES;

EID: 84869496990     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2012.10.007     Document Type: Article

References (169)

1. E. Zerhouni The NIH roadmap Science 302 5642 2003 63 72
2. A. Wei Focus on the advances in nanomedicine symposium, 233rd National Meeting of the American Chemical Society, 2006 Nanomedicine 2 1 2007 83
3. V.P. Torchilin Micellar nanocarriers: pharmaceutical perspectives Pharm. Res. 24 1 2007 1 16
4. A.G. Cuenca, H. Jiang, S.N. Hochwald, M. Delano, W.G. Cance, and S.R. Grobmyer Emerging implications of nanotechnology on cancer diagnostics and therapeutics Cancer 107 3 2006 459 466
5. S.R. Grobmyer, and B.M. Moudgil Cancer nanotechnology: methods and protocols Methods in Molecular Biology Vol. 624 2011 Humana Press Inc. Totowa
6. 99mTc labeling of PEGylated liposomal doxorubicin (Doxil) for pharmacokinetic and non-invasive imaging studies J. Pharmacol. Exp. Ther. 308 2 2004 419 425
7. K.-H. Chuang, H.-E. Wang, F.-M. Chen, S.-C. Tzou, C.-M. Cheng, Y.-C. Chang, W.-L. Tseng, J. Shiea, S.-R. Lin, J.-Y. Wang, B.-M. Chen, S.R. Roffler, and T.-L. Cheng Endocytosis of pegylated agents enhances cancer imaging and anticancer efficacy Mol. Cancer Ther. 9 6 2010 1903 1912
8. Y. Barenholz Doxil® - the first FDA-approved nano-drug: lessons learned J. Control. Release 160 2 2012 117 134
9. M.R. Green, G.M. Manikhas, S. Orlov, B. Afanasyev, A.M. Makhson, P. Bhar, and M.J. Hawkins Abraxane®, a novel Cremophor®-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer Ann. Oncol. 17 8 2006 1263 1268
10. It should be noted that nanoscale formulations do not always result in nanoscale drug delivery; for instance, the nanoparticles in Abraxane® readily dissociate into individual drug-bound albumin species after injection See: N. Desai, Nab Technology: a Drug Delivery Platform Utilizing Endothelial gp60 Receptor-based Transport and Tumour-derived SPARC for Targeting 16th ed. Drug Delivery Report 2007 37 41
11. O.R. Deitcher, S. O'Brien, S.R. Deitcher, D.A. Thomas, and H.M. Kantarjian Single-agent vincristine sulfate liposomes injection (Marqibo®) compared to historical single-agent therapy for adults with advanced, relapsed and/or refractory Philadelphia chromosome negative acute lymphoblastic leukemia Blood 118 21 2011 1112 1113
12. R. Duncan, and R. Gaspar Nanomedicine(s) under the microscope Mol. Pharm. 8 6 2011 2101 2141
13. A.Z. Wang, R. Langer, and O.C. Farokhzad Nanoparticle delivery of cancer drugs Annu. Rev. Med. 63 1 2012 185 198
14. T. Lammers, F. Kiessling, W.E. Hennink, and G. Storm Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress J. Control. Release 161 2 2012 175 187
15. C.E. Petre, and D.P. Dittmer Liposomal daunorubicin as treatment for Kaposi's sarcoma Int. J. Nanomedicine 2 3 2007 277 288
16. Y.-X.J. Wang Superparamagnetic iron oxide based MRI contrast agents: current status of clinical application Quant. Imaging Med. Surg. 1 1 2011 35 40
17. P. Goodwill, K.M. Krishnan, and S.M. Conolly N.T.K. Thanh, Magnetic Nanoparticles: from Fabrication to Clinical Applications 2012 CRC Press Boca Raton 523 540
18. K. Maier-Hauff, F. Ulrich, D. Nestler, H. Niehoff, P. Wust, B. Thiesen, H. Orawa, V. Budach, and A. Jordan Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme J. Neuro-Oncol. 103 2 2011 317 324
19. Z.L. Feng, G. Zhao, L. Yu, D. Gough, and S.B. Howell Preclinical efficacy studies of a novel nanoparticle-based formulation of paclitaxel that out-performs Abraxane Cancer Chemother. Pharmacol. 65 5 2010 923 930
20. D.D. Von Hoff, G. Jameson, M.J. Borad, L.S. Rosen, J. Utz, S. Dhar, L. Acosta, T. Barker, J. Walling, and J.T. Hamm First phase I trial of NKTR-102 (PEG-irinotecan) reveals early evidence of broad anti-tumor activity in three schedules EJC Suppl. 6 12 2008 186 (20th EORTC-NCI-AACR Mol. Symp. Mol. Targets & Cancer Therapeutics, Poster #595)
21. C.D. Landon, J.-Y. Park, D. Needham, and M.W. Dewhirst Nanoscale drug delivery and hyperthermia: the materials design and preclinical and clinical testing of low temperature-sensitive liposomes used in combination with mild hyperthermia in the treatment of local cancer Open Nanomed. J. 3 2011 38 64
22. D.-W. Kim, S.-Y. Kim, H.-K. Kim, S.-W. Kim, S.W. Shin, J.S. Kim, K. Park, M.Y. Lee, and D.S. Heo Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer Ann. Oncol. 18 12 2007 2009 2014
23. M.W. Saif, N.A. Podoltsev, M.S. Rubin, J.A. Figueroa, M.Y. Lee, J. Kwon, E. Rowen, J. Yu, and R.O. Kerr Phase II clinical trial of paclitaxel loaded polymeric micelle in patients with advanced pancreatic cancer Cancer Invest. 28 2 2011 186 194
24. A. Dicko, S. Kwak, A.A. Frazier, L.D. Mayer, and B.D. Liboiron Biophysical characterization of a liposomal formulation of cytarabine and daunorubicin Int. J. Pharm. 391 1-2 2010 248 259
25. E.J. Feldman, J.E. Kolitz, J.M. Trang, B.D. Liboiron, C.E. Swenson, M.T. Chiarella, L.D. Mayer, A.C. Louie, and J.E. Lancet Pharmacokinetics of CPX-351; a nano-scale liposomal fixed molar ratio formulation of cytarabine:daunorubicin, in patients with advanced leukemia Leuk. Res. 36 10 2012 1283 1289
26. E.M. Gordon, and F.L. Hall Rexin-G, a targeted genetic medicine for cancer Expert. Opin. Biol. Ther. 10 5 2010 819 832
27. M.E. Davis Design and development of IT-101, a cyclodextrin-containing polymer conjugate of camptothecin Adv. Drug Deliv. Rev. 61 13 2009 1189 1192
28. M.D. Walsh, S.K. Hanna, J. Sen, S. Rawal, C.B. Cabral, A.V. Yurkovetskiy, R.J. Fram, T.B. Lowinger, and W.C. Zamboni Pharmacokinetics and antitumor efficacy of XMT-1001, a novel, polymeric topoisomerase I inhibitor, in mice bearing HT-29 human colon carcinoma xenografts Clin. Cancer Res. 18 9 2012 2591 2602
29. M.E. Davis The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic Mol. Pharm. 6 3 2009 659 668
30. M.E. Davis, J.E. Zuckerman, C.H.J. Choi, D. Seligson, A. Tolcher, C.A. Alabi, Y. Yen, J.D. Heidel, and A. Ribas Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles Nature 464 7291 2010 1067 1070
31. J. Shi, Z. Xiao, N. Kamaly, and O.C. Farokhzad Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation Acc. Chem. Res. 44 10 2011 1123 1134
32. J. Hrkach, D. von Hoff, M.M. Ali, E. Andrianova, J. Auer, T. Campbell, D. De Witt, M. Figa, M. Figueiredo, A. Horhota, S. Low, K. McDonnell, E. Peeke, B. Retnarajan, A. Sabnis, E. Schnipper, J.J. Song, Y.H. Song, J. Summa, D. Tompsett, G. Troiano, T. Van geen Hoven, J. Wright, P. LoRusso, P.W. Kantoff, N.H. Bander, C. Sweeney, O.C. Farokhzad, R. Langer, and S. Zale Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile Sci. Transl. Med. 4 2012 128ra139
33. S.K. Libutti, G.F. Paciotti, A.A. Byrnes, H.R. Alexander, W.E. Gannon, M. Walker, G.D. Seidel, N. Yuldasheva, and L. Tamarkin Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine Clin. Cancer Res. 16 24 2010 6139 6149
34. M.M. Jain, C.D. Deshmukh, N.N. Bhatt, S.A. Bondarde, R.V. Nagarkar, and C.J.D.G.H. Divekar Phase I, PK, dose-finding, active controlled study of paclitaxel injection concentrate for nanodispersion (PICN) in subjects with metastatic breast cancer J. Clin. Oncol. 29 2011 [(Suppl.) abstr. e11585]
35. L. Levy, A. Herrera, P. Devauchelle, S. Bonvalot, E. Deutsch, and C. Le Pechoux NBTXR3 nanoparticles for radioenhancement: rationale for the first-in-man study in advanced soft tissue sarcoma Ann. Oncol. 23 Suppl. 1 2012 17 18
36. S. Lal, S.E. Clare, and N.J. Halas Nanoshell-enabled photothermal cancer therapy: impending clinical impact Acc. Chem. Res. 41 12 2008 1842 1851
37. M. Benezra, O. Penate-Medina, P.B. Zanzonico, D. Schaer, H. Ow, A. Burns, E. DeStanchina, V. Longo, E. Herz, S. Iyer, J. Wolchok, S.M. Larson, U. Wiesner, and M.S. Bradbury Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma J. Clin. Invest. 121 7 2011 2768 2780
38. R.K. Jain, and T. Stylianopoulos Delivering nanomedicine to solid tumors Nat. Rev. Clin. Oncol. 7 11 2010 653 664
39. B.R. Smith, P. Kempen, D. Bouley, A. Xu, Z. Liu, N. Melosh, H. Dai, R. Sinclair, and S.S. Gambhir Shape matters: intravital microscopy reveals surprising geometrical dependence for nanoparticles in tumor models of extravasation Nano Lett. 12 7 2012 3369 3377
40. B.D. Chithrani, A.A. Ghazani, and W.C.W. Chan Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells Nano Lett. 6 4 2006 662 668
41. W. Jiang, B.Y.S. Kim, J.T. Rutka, and W.C.W. Chan Nanoparticle-mediated cellular response is size-dependent Nat. Nanotechnol. 3 3 2008 145 150
42. H. Maeda Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects Bioconjug. Chem. 21 5 2010 797 802
43. S.D. Perrault, C. Walkey, T. Jennings, H.C. Fischer, and W.C.W. Chan Mediating tumor targeting efficiency of nanoparticles through design Nano Lett. 9 5 2009 1909 1915
44. M.R. Dreher, W. Liu, C.R. Michelich, M.W. Dewhirst, F. Yuan, and A. Chilkoti Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers J. Natl. Cancer Inst. 98 5 2006 335 344
45. H. Sarin, A.S. Kanevsky, H.T. Wu, A.A. Sousa, C.M. Wilson, M.A. Aronova, G.L. Griffiths, R.D. Leapman, and H.Q. Vo Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors J. Transl. Med. 51 2009 (13 pages)
46. V.P. Chauhan, T. Stylianopoulos, J.D. Martin, Z. Popovic, O. Chen, W.S. Kamoun, M.G. Bawendi, D. Fukumura, and R.K. Jain Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner Nat. Nanotechnol. 7 6 2012 383 388
47. N. Khlebtsov, and L. Dykman Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies Chem. Soc. Rev. 40 3 2012 1647 1671
48. J. Park, D.-H. Lim, H.-J. Lim, T. Kwon, J.-S. Choi, S. Jeong, I.-H. Choi, and J. Cheon Size dependent macrophage responses and toxicological effects of Ag nanoparticles Chem. Commun. 47 15 2011 4382 4384
49. 4@Au nanoparticles and nanostars Nanoscale 4 22 2012 7143 7148
50. H. Kobayashi, and M.W. Brechbiel Dendrimer-based macromolecular MRI contrast agents: characteristics and application Mol. Imaging 2 1 2003 1 10
51. H.S. Choi, W. Liu, P. Misra, E. Tanaka, J.P. Zimmer, B. Itty Ipe, M.G. Bawendi, and J.V. Frangioni Renal clearance of quantum dots Nat. Biotechnol. 25 10 2007 1165 1170
52. M.E. Fox, F.C. Szoka, and J.M.J. Fréchet Soluble polymer carriers for the treatment of cancer: the importance of molecular architecture Acc. Chem. Res. 42 8 2009 1141 1151
53. S. Xu, Z. Nie, M. Seo, P. Lewis, E. Kumacheva, H.A. Stone, P. Garstecki, D.B. Weibel, I. Gitlin, and G.M. Whitesides Generation of monodisperse particles by using microfluidics: control over size, shape, and composition Angew. Chem. Int. Ed. 44 25 2005 724 728
54. B.J. Berne, and R. Pecora Dynamic Light Scattering: with Applications to Chemistry, Biology, and Physics 2000 Dover Publications Mineola, N.Y.
55. J.S. Philo A critical review of methods for size characterization of non-particulate protein aggregates Curr. Pharm. Biotechnol. 10 4 2009 359 372
56. W. Fraunhofer, G. Winter, and C. Coester Asymmetrical flow field-flow fractionation and multiangle light scattering for analysis of gelatin nanoparticle drug carrier systems Anal. Chem. 76 7 2004 1909 1920
57. A. Bootz, V. Vogel, D. Schubert, and J. Kreuter Comparison of scanning electron microscopy, dynamic light scattering and analytical ultracentrifugation for the sizing of poly(butyl cyanoacrylate) nanoparticles Eur. J. Pharm. Biopharm. 57 2 2004 369 375
58. J. Liu, J. Andya, and S. Shire A critical review of analytical ultracentrifugation and field flow fractionation methods for measuring protein aggregation AAPS J. 8 3 2006 E580 E589
59. J.M. Zook, V. Rastogi, R.I. MacCuspie, A.M. Keene, and J. Fagan Measuring agglomerate size distribution and dependence of localized surface plasmon resonance absorbance on gold nanoparticle agglomerate size using analytical ultracentrifugation ACS Nano 5 10 2011 8070 8079
60. Y. Luo, T. Matejic, C.-K. Ng, B. Nunnally, T. Porter, S. Raso, J. Rouse, T. Shang, J. Steckert, A. Satinder, and S. Stephen Separation Science and Technology Vol. 10 2011 Academic Press 283 359
61. Q. Huo Protein complexes/aggregates as potential cancer biomarkers revealed by a nanoparticle aggregation immunoassay Colloids Surf. B 78 2 2010 259 265
62. Q. Dai, X. Liu, J. Coutts, L. Austin, and Q. Huo A one-step highly sensitive method for DNA detection using dynamic light scattering J. Am. Chem. Soc. 130 26 2008 8138 8139
63. R. Vogel, G. Willmott, D. Kozak, G.S. Roberts, W. Anderson, L. Groenewegen, B. Glossop, A. Barnett, A. Turner, and M. Trau Quantitative sizing of nano/microparticles with a tunable elastomeric pore sensor Anal. Chem. 83 9 2011 3499 3506
64. G.S. Roberts, D. Kozak, W. Anderson, M.F. Broom, R. Vogel, and M. Trau Tunable nano/micropores for particle detection and discrimination: scanning ion occlusion spectroscopy Small 6 23 2010 2653 2658
65. I. Montes-Burgos, D. Walczyk, P. Hole, J. Smith, I. Lynch, and K. Dawson Characterisation of nanoparticle size and state prior to nanotoxicological studies J. Nanoparticle Res. 12 1 2010 47 53
66. V. Filipe, A. Hawe, and W. Jiskoot Critical evaluation of nanoparticle tracking analysis (nta) by nanosight for the measurement of nanoparticles and protein aggregates Pharm. Res. 27 5 2010 796 810
67. N.C. Bell, C. Minelli, J. Tompkins, M.M. Stevens, and A.G. Shard Emerging techniques for submicrometer particle sizing applied to Stöber silica Langmuir 28 29 2012 10860 10872
68. R.S. Krishnan, and S.R. Sivarajan Scattering of polarised light by colloids containing anisotropic particles Proc. Indian Acad. Sci., Sec. A 44 5 1956 274 278
69. H.P. Schwarcz, and K.C. Shane Measurement of particle shape by Fourier analysis Sedimentology 13 3-4 1969 213 231
70. N. Loren, L. Hamberg, and A.M. Hermansson Measuring shapes for application in complex food structures Food Hydrocolloids 20 5 2006 712 722
71. M.V. Petoukhov, and D.I. Svergun Analysis of X-ray and neutron scattering from biomacromolecular solutions Curr. Opin. Struct. Biol. 17 5 2007 562 571
72. N.K. Reddy, J. Pérez-Juste, I. Pastoriza-Santos, P.R. Lang, J.K.G. Dhont, L.M. Liz-Marzán, and J. Vermant Flow dichroism as a reliable method to measure the hydrodynamic aspect ratio of gold nanoparticles ACS Nano 5 6 2011 4935 4944
73. Y. Barenholz Amphipathic weak base loading into preformed liposomes having a transmembrane ammonium ion gradient: from the bench to approved DOXIL G. Gregoriadis, 3rd ed. Liposome Technology: Entrapment of Drugs and Other Materials into Liposomes vol. 2 2007 Informa Healthcare New York 1 25
74. J. Park, K. An, Y. Hwang, J.-G. Park, H.-J. Noh, J.-Y. Kim, J.-H. Park, N.-M. Hwang, and T. Hyeon Ultra-large-scale syntheses of monodisperse nanocrystals Nat. Mater. 3 12 2004 891 895
75. Y. Xia, Y. Xiong, B. Lim, and Sara E. Skrabalak Shape-controlled synthesis of metal nanocrystals: simple chemistry meets complex physics? Angew. Chem. Int. Ed. 48 1 2009 60 103
76. J.I. Park, A. Saffari, S. Kumar, A. Günther, and E. Kumacheva Microfluidic synthesis of polymer and inorganic particulate materials Annu. Rev. Mater. Res. 40 1 2010 415 443
77. M. Drobot Continuous flow microreactors in nanoparticle synthesis Spec. Chem. Mag. 32 5 2012 40 41
78. H.D. Jin, A. Garrison, T. Tseng, B.K. Paul, and C.-H. Chang High-rate synthesis of phosphine-stabilized undecagold nanoclusters using a multilayered micromixer Nanotechnology 21 44 2010 445604
79. J. Wagner, and J.M. Köhler Continuous synthesis of gold nanoparticles in a microreactor Nano Lett. 5 4 2005 685 691
80. K.J. Hartlieb, C.L. Raston, and M. Saunders Controlled scalable synthesis of ZnO nanoparticles Chem. Mater. 19 23 2007 5453 5459
81. S. Marre, and K.F. Jensen Synthesis of micro and nanostructures in microfluidic systems Chem. Soc. Rev. 39 3 2010 1183 1202
82. L. Capretto, S. Mazzitelli, E. Brognara, I. Lampronti, D. Carugo, M. Hill, X. Zhang, R. Gambari, and C. Nastruzzi Mithramycin encapsulated in polymeric micelles by microfluidic technology as novel therapeutic protocol for beta-thalassemia Int. J. Nanomed. 7 1 2012 307 324
83. J.W. Loh, J. Schneider, M. Carter, M. Saunders, and L.Y. Lim Spinning disc processing technology: potential for large-scale manufacture of chitosan nanoparticles J. Pharm. Sci. 99 10 2010 4326 4336
84. J.L. Perry, K.P. Herlihy, M.E. Napier, and J.M. DeSimone PRINT: a novel platform toward shape and size specific nanoparticle theranostics Acc. Chem. Res. 44 10 2011 990 998
85. Y. Wang, J.D. Byrne, M.E. Napier, and J.M. DeSimone Engineering nanomedicines using stimuli-responsive biomaterials Adv. Drug Deliv. Rev. 64 11 2012 1021 1030
86. J.-T. Wang, J. Wang, and J.-J. Han Fabrication of advanced particles and particle-based materials assisted by droplet-based microfluidics Small 7 13 2011 1728 1754
87. S.-D. Li, and L. Huang Pharmacokinetics and biodistribution of nanoparticles Mol. Pharm. 5 4 2008 496 504
88. M.A. Dobrovolskaia, and S.E. McNeil Immunological properties of engineered nanomaterials Nat. Nanotechnol. 2 8 2007 469 478
89. P. Poulin, and S. Haddad Advancing prediction of tissue distribution and volume of distribution of highly lipophilic compounds from a simplified tissue-composition-based model as a mechanistic animal alternative method J. Pharm. Sci. 101 6 2012 2250 2261
90. A. Rostami-Hodjegan Physiologically based pharmacokinetics joined with in vitro-in vivo extrapolation of ADME: a marriage under the arch of systems pharmacology Clin. Pharmacol. Ther. 92 1 2012 50 61
91. R. Landsiedel, E. Fabian, L. Ma-Hock, W. Wohlleben, K. Wiench, F. Oesch, and B. van Ravenzwaay Toxico-/biokinetics of nanomaterials Arch. Toxicol. 86 7 2012 1021 1060
92. G.T. Tucker An agenda for UK clinical pharmacology: research priorities in pharmacokinetics Br. J. Clin. Pharmacol. 73 6 2012 924 926
93. W.P. Walters Going further than Lipinski's rule in drug design Expert Opin. Drug Discov. 7 2 2012 99 107
94. S. Hussain, J.A.J. Vanoirbeek, and P.H.M. Hoet Interactions of nanomaterials with the immune system Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 4 2 2011 169 183
95. M. Bartneck, H.A. Keul, S. Singh, K. Czaja, J. Bornemann, M. Bockstaller, M. Moeller, G. Zwadlo-Klarwasser, and J. Groll Rapid uptake of gold nanorods by primary human blood phagocytes and immunomodulatory effects of surface chemistry ACS Nano 4 6 2010 3073 3086
96. X.D. Zhang, D. Wu, X. Shen, P.X. Liu, N. Yang, B. Zhao, H. Zhang, Y.M. Sun, L.A. Zhang, and F.Y. Fan Size-dependent in vivo toxicity of PEG-coated gold nanoparticles Int. J. Nanomed. 6 2011 2071 2081
97. W.-S. Cho, M. Cho, J. Jeong, M. Choi, H.-Y. Cho, B.S. Han, S.H. Kim, H.O. Kim, Y.T. Lim, B.H. Chung, and J. Jeong Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles Toxicol. Appl. Pharmacol. 236 1 2009 16 24
98. T.B. Huff, M.N. Hansen, Y. Zhao, J.-X. Cheng, and A. Wei Controlling the cellular uptake of gold nanorods Langmuir 23 4 2007 1596 1599
99. A.P. Leonov, J. Zheng, J.D. Clogston, S.T. Stern, A.K. Patri, and A. Wei Detoxification of gold nanorods by treatment with polystyrenesulfonate ACS Nano 2 12 2008 2481 2488
100. C.J. Murphy, A.M. Gole, J.W. Stone, P.N. Sisco, A.M. Alkilany, E.C. Goldsmith, and S.C. Baxter Gold nanoparticles in biology: beyond toxicity to cellular imaging Acc. Chem. Res. 41 12 2008 1721 1730
101. A. Wei, A.P. Leonov, and Q.S. Wei Gold nanorods: multifunctional agents for cancer imaging and therapy S.R. Grobmyer, B.M. Moudgil, Cancer Nanotechnology: Methods and Protocols Vol. 624 2011 Humana Press Inc. Totowa 119 130
102. M. Kumagai, T.K. Sarma, H. Cabral, S. Kaida, M. Sekino, N. Herlambang, K. Osada, M.R. Kano, N. Nishiyama, and K. Kataoka Enhanced in vivo magnetic resonance imaging of tumors by PEGylated iron-oxide-gold core-shell nanoparticles with prolonged blood circulation properties Macromol. Rapid Commun. 31 17 2010 1521 1528
103. G. Prencipe, S.M. Tabakman, K. Welsher, Z. Liu, A.P. Goodwin, L. Zhang, J. Henry, and H.J. Dai PEG branched polymer for functionalization of nanomaterials with ultralong blood circulation J. Am. Chem. Soc. 131 13 2009 4783 4787
104. L. Tong, W. He, Y. Zhang, W. Zheng, and J.-X. Cheng Visualizing systemic clearance and cellular level biodistribution of gold nanorods by intrinsic two-photon luminescence Langmuir 25 21 2009 12454 12459
105. D.P.K. Lankveld, R.G. Rayavarapu, P. Krystek, A.G. Oomen, H.W. Verharen, T.G. van Leeuwen, W.H. De Jong, and S. Manohar Blood clearance and tissue distribution of PEGylated and non-PEGylated gold nanorods after intravenous administration in rats Nanomedicine 6 2 2011 339 349
106. Y. Akiyama, T. Mori, Y. Katayama, and T. Niidome The effects of PEG grafting level and injection dose on gold nanorod biodistribution in the tumor-bearing mice J. Control. Release 139 1 2009 81 84
107. G. von Maltzahn, J.-H. Park, A. Agrawal, N.K. Bandaru, S.K. Das, M.J. Sailor, and S.N. Bhatia Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas Cancer Res. 69 9 2009 3892 3900
108. G.P. Goodrich, L.L. Bao, K. Gill-Sharp, K.L. Sang, J. Wang, and J.D. Payne Photothermal therapy in a murine colon cancer model using near-infrared absorbing gold nanorods J. Biomed. Opt. 15 1 2010 018001
109. G. Zhang, Z. Yang, W. Lu, R. Zhang, Q. Huang, M. Tian, L. Li, D. Liang, and C. Li Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice Biomaterials 30 10 2009 1928 1936
110. M. Malmsten, K. Emoto, and J.M. Van Alstine Effect of chain density on inhibition of protein adsorption by poly(ethylene glycol) based coatings J. Colloid Interface Sci. 202 2 1998 507 517
111. L.D. Unsworth, H. Sheardown, and J.L. Brash Protein-resistant poly(ethylene oxide)-grafted surfaces: chain density-dependent multiple mechanisms of action Langmuir 24 5 2008 1924 1929
112. N. Ngadi, J. Abrahamson, C. Fee, and K. Morison Are PEG molecules a universal protein repellent? World Acad. Sci. Eng. Technol. 49 2009 144 148
113. T.-L. Cheng, K.-H. Chuang, B.-M. Chen, and S.R. Roffler Analytical measurement of PEGylated molecules Bioconjug. Chem. 23 5 2012 881 899
114. H. Otsuka, Y. Nagasaki, and K. Kataoka PEGylated nanoparticles for biological and pharmaceutical applications Adv. Drug Deliv. Rev. 55 3 2003 403 419
115. A.S. Karakoti, S. Das, S. Thevuthasan, and S. Seal PEGylated inorganic nanoparticles Angew. Chem. Int. Ed. 50 9 2011 1980 1994
116. N.V. Efremova, S.R. Sheth, and D.E. Leckband Protein-induced changes in poly(ethylene glycol) brushes: molecular weight and temperature dependence Langmuir 17 24 2001 7628 7636
117. M. Heuberger, T. Drobek, and N.D. Spencer Interaction forces and morphology of a protein-resistant poly(ethylene glycol) layer Biophys. J. 88 1 2005 495 504
118. A.L. Klibanov, K. Maruyama, A.M. Beckerleg, V.P. Torchilin, and L. Huang Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target Biochim. Biophys. Acta Biomembr. 1062 2 1991 142 148
119. T.M. Allen Ligand-targeted therapeutics in anticancer therapy Nat. Rev. Cancer 2 10 2002 750 763
120. S. Hak, E. Helgesen, H.H. Hektoen, E.M. Huuse, P.A. Jarzyna, W.J.M. Mulder, O. Haraldseth, and C.D.L. Davies The effect of nanoparticle polyethylene glycol surface density on ligand-directed tumor targeting studied in vivo by dual modality imaging ACS Nano 6 6 2012 5648 5658
121. X. Huang, X. Peng, Y. Wang, Y. Wang, D.M. Shin, M.A. El-Sayed, and S. Nie A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands ACS Nano 4 10 2010 5887 5896
122. H. Sarin Overcoming the challenges in the effective delivery of chemotherapies to CNS solid tumors Ther. Deliv. 1 2 2010 289 305
123. A.K. Patri, unpublished results.
124. W. Xia, and P.S. Low Folate-targeted therapies for cancer J. Med. Chem. 53 19 2010 6811 6824
125. T.B. Huff, L. Tong, Y. Zhao, M.N. Hansen, J.-X. Cheng, and A. Wei Hyperthermic effects of gold nanorods on tumor cells Nanomedicine 2 1 2007 125 132
126. S.D. Swanson, J.F. Kukowska-Latallo, A.K. Patri, C.Y. Chen, S. Ge, Z.Y. Cao, A. Kotlyar, A.T. East, and J.R. Baker Targeted gadolinium-loaded dendrimer nanoparticles for tumor-specific magnetic resonance contrast enhancement Int. J. Nanomed. 3 2 2008 201 210
127. T. Pons, I.L. Medintz, X. Wang, D.S. English, and H. Mattoussi Solution-phase single quantum dot fluorescence resonance energy transfer J. Am. Chem. Soc. 128 47 2006 15324 15331
128. L.M. Demers, C.A. Mirkin, R.C. Mucic, R.A. Reynolds III, R.L. Letsinger, R. Elghanian, and G. Viswanadham A fluorescence-based method for determining the surface coverage and hybridization efficiency of thiol-capped oligonucleotides bound to gold thin films and nanoparticles Anal. Chem. 72 22 2000 5535 5541
129. L. Maus, J.P. Spatz, and R. Fiammengo Quantification and reactivity of functional groups in the ligand shell of PEGylated gold nanoparticles via a fluorescence-based assay Langmuir 25 14 2009 7910 7917
130. X. Wang, O. Ramstrom, and M. Yan A photochemically initiated chemistry for coupling underivatized carbohydrates to gold nanoparticles J. Mater. Chem. 19 47 2009 8944 8949
131. X. Wang, O. Ramström, and M. Yan Quantitative analysis of multivalent ligand presentation on gold glyconanoparticles and the impact on lectin binding Anal. Chem. 82 21 2011 9082 9089
132. W. He, W.A. Henne, Q. Wei, Y. Zhao, D.D. Doorneweerd, J.-X. Cheng, P.S. Low, and A. Wei Two-photon luminescence imaging of Bacillus spores using peptide-functionalized gold nanorods Nano Res. 1 6 2008 450 456
133. K.M. Harkness, B.C. Hixson, L.S. Fenn, B.N. Turner, A.C. Rape, C.A. Simpson, B.J. Huffman, T.C. Okoli, J.A. McLean, and D.E. Cliffel A structural mass spectrometry strategy for the relative quantitation of ligands on mixed monolayer-protected gold nanoparticles Anal. Chem. 82 22 2010 9268 9274
134. S. Elzey, D.-H. Tsai, S. Rabb, L. Yu, M. Winchester, and V. Hackley Quantification of ligand packing density on gold nanoparticles using ICP-OES Anal. Bioanal. Chem. 403 1 2012 145 149
135. Y.L. Li, and M.L. Gross Ionic-liquid matrices for quantitative analysis by MALDI-TOF mass spectrometry J. Am. Soc. Mass Spectrom. 15 12 2004 1833 1837
136. M. Mrksich Mass spectrometry of self-assembled monolayers: a new tool for molecular surface science ACS Nano 2 1 2008 7 18
137. Z.J. Zhu, Y.C. Yeh, R. Tang, B. Yan, J. Tamayo, R.W. Vachet, and V.M. Rotello Stability of quantum dots in live cells Nat. Chem. 3 12 2011 963 968
138. B. Yan, Z.J. Zhu, O.R. Miranda, A. Chompoosor, V.M. Rotello, and R.W. Vachet Laser desorption/ionization mass spectrometry analysis of monolayer-protected gold nanoparticles Anal. Bioanal. Chem. 396 3 2010 1025 1035
139. S. Ju, and W.-S. Yeo Quantification of proteins on gold nanoparticles by combining MALDI-TOF MS and proteolysis Nanotechnology 23 13 2012 135701
140. S. Guha, X. Ma, M.J. Tarlov, and M.R. Zachariah Quantifying ligand adsorption to nanoparticles using tandem differential mobility mass analysis Anal. Chem. 84 15 2012 6308 6311
141. S. Guha, M.D. Li, M.J. Tarlov, and M.R. Zechariah Electrospray- differential mobility analysis of bionanoparticles Trends Biotechnol. 30 5 2012 291 300
142. F. Kienberger, A. Ebner, H.J. Gruber, and P. Hinterdorfer Molecular recognition imaging and force spectroscopy of single biomolecules Acc. Chem. Res. 39 1 2005 29 36
143. E.M. Puchner, and H.E. Gaub Force and function: probing proteins with AFM-based force spectroscopy Curr. Opin. Struct. Biol. 19 5 2009 605 614
144. A.R. Bizzarri, and S. Cannistraro Atomic force spectroscopy in biological complex formation: strategies and perspectives J. Phys. Chem. B 113 52 2009 16449 16464
145. C.H.J. Choi, J.E. Zuckerman, P. Webster, and M.E. Davis Targeting kidney mesangium by nanoparticles of defined size Proc. Natl. Acad. Sci. USA 108 16 2011 6656 6661
146. S.M. Moghimi, A.C. Hunter, and T.L. Andresen Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective Annu. Rev. Pharmacol. Toxicol. 52 1 2012 481 503
147. Y. Geng, P. Dalhaimer, S. Cai, R. Tsai, M. Tewari, T. Minko, and D.E. Discher Shape effects of filaments versus spherical particles in flow and drug delivery Nat. Nanotechnol. 2 4 2007 249 255
148. V.V. Shuvaev, M.A. Ilies, E. Simone, S. Zaitsev, Y. Kim, S. Cai, A. Mahmud, T. Dziubla, S. Muro, D.E. Discher, and V.R. Muzykantov Endothelial targeting of antibody-decorated polymeric filomicelles ACS Nano 5 9 2011 6991 6999
149. A.S. Thakor, J.V. Jokerst, C.L. Zavaleta, T.F. Massoud, and S.S. Gambhir Gold nanoparticles: a revival in precious metal administration to patients Nano Lett. 11 10 2011 4029 4036
150. Y. Cheng, J.D. Meyers, A.-M. Broome, M.E. Kenney, J.P. Basilion, and C. Burda Deep penetration of a PDT drug into tumors by noncovalent drug-gold nanoparticle conjugates J. Am. Chem. Soc. 133 8 2011 2583 2591
151. W.-S. Cho, M. Cho, J. Jeong, M. Choi, B.S. Han, H.-S. Shin, J. Hong, B.H. Chung, J. Jeong, and M.-H. Cho Size-dependent tissue kinetics of PEG-coated gold nanoparticles Toxicol. Appl. Pharmacol. 245 1 2010 116 123
152. B.D. Chithrani, and W.C.W. Chan Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes Nano Lett. 7 6 2007 1542 1550
153. E.C. Dreaden, A.M. Alkilany, X. Huang, C.J. Murphy, and M.A. El-Sayed The golden age: gold nanoparticles for biomedicine Chem. Soc. Rev. 41 7 2012 2740 2779
154. E.B. Dickerson, E.C. Dreaden, X. Huang, I.H. El-Sayed, H. Chu, S. Pushpanketh, J.F. McDonald, and M.A. El-Sayed Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice Cancer Lett. 269 1 2008 57 66
155. M. Eghtedari, A. Oraevsky, J.A. Copland, N. Kotov, A. Conjusteau, and M. Motamedi High sensitivity of in vivo detection of gold nanorods using a laser optoacoustic imaging system Nano Lett. 7 7 2007 1914 1918
156. A.L. Oldenburg, M.N. Hansen, T.S. Ralston, A. Wei, and S.A. Boppart Imaging gold nanorods in excised human breast carcinoma by spectroscopic optical coherence tomography J. Mater. Chem. 19 35 2009 6407 6411
157. C. Kim, H.-M. Song, X. Cai, J. Yao, A. Wei, and L.V. Wang In vivo photoacoustic mapping of lymphatic systems with plasmon-resonant nanostars J. Mater. Chem. 21 9 2011 2841 2844
158. S.K. Balasubramanian, J. Jittiwat, J. Manikandan, C.-N. Ong, L.E. Yu, and W.-Y. Ong Biodistribution of gold nanoparticles and gene expression changes in the liver and spleen after intravenous administration in rats Biomaterials 31 8 2010 2034 2042
159. G. Wu, A. Mikhailovsky, H.A. Khant, C. Fu, W. Chiu, and J.A. Zasadzinski Remotely triggered liposome release by near-infrared light absorption via hollow gold nanoshells J. Am. Chem. Soc. 130 26 2008 8175 8177
160. A. Wijaya, S.B. Schaffer, I.G. Pallares, and K. Hamad-Schifferli Selective release of multiple DNA oligonucleotides from gold nanorods ACS Nano 3 1 2009 80 86
161. G.B. Braun, A. Pallaoro, G. Wu, D. Missirlis, J.A. Zasadzinski, M. Tirrell, and N.O. Reich Laser-activated gene silencing via gold nanoshell-siRNA conjugates ACS Nano 3 7 2009 2007 2015
162. W. Lu, G. Zhang, R. Zhang, L.G. Flores, Q. Huang, J.G. Gelovani, and C. Li Tumor site-specific silencing of NF-kB p65 by targeted hollow gold nanosphere-mediated photothermal transfection Cancer Res. 70 8 2010 3177 3188
163. R. Huschka, J. Zuloaga, M.W. Knight, L.V. Brown, P. Nordlander, and N.J. Halas Light-induced release of DNA from gold nanoparticles: nanoshells and nanorods J. Am. Chem. Soc. 133 31 2011 12247 12255
164. T.S. Hauck, T.L. Jennings, T. Yatsenko, J.C. Kumaradas, and W.C.W. Chan Enhancing the toxicity of cancer chemotherapeutics with gold nanorod hyperthermia Adv. Mater. 20 20 2008 3832 3838
165. H. Park, J. Yang, J. Lee, S. Haam, I.-H. Choi, and K.-H. Yoo Multifunctional nanoparticles for combined doxorubicin and photothermal treatments ACS Nano 3 10 2009 2919 2926
166. H.C. Huang, Y. Yang, A. Nanda, P. Koria, and K. Rege Synergistic administration of photothermal therapy and chemotherapy to cancer cells using polypeptide-based degradable plasmonic matrices Nanomedicine 6 3 2011 459 473
167. S.H. Hu, T.Y. Liu, D.M. Liu, and S.Y. Chen Nano-ferrosponges for controlled drug release J. Control. Release 121 3 2007 181 189
168. S.D. Kong, W. Zhang, J.H. Lee, K. Brammer, R. Lal, M. Karin, and S. Jin Magnetically vectored nanocapsules for tumor penetration and remotely switchable on-demand drug release Nano Lett. 10 12 2010 5088 5092
169. C.R. Thomas, D.P. Ferris, J.H. Lee, E. Choi, M.H. Cho, E.S. Kim, J.F. Stoddart, J.S. Shin, J. Cheon, and J.I. Zink Noninvasive remote-controlled release of drug molecules in vitro using magnetic actuation of mechanized nanoparticles J. Am. Chem. Soc. 132 31 2010 10623 10625